Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 380 | -1,940 | 984 | 2,030 | 1,124 |
| Cost of Goods | 133 | -4,541 | 1,850 | 2,424 | 1,045 |
| Gross Profit | 247 | 2,601 | -866 | -394 | 79 |
| Operating Expenses | 3,397 | 17,253 | 13,588 | 13,598 | 11,484 |
| Operating Income | -3,017 | -15,193 | -13,604 | -13,568 | -11,360 |
| Interest Expense | 30 | 42 | 50 | 49 | 68 |
| Other Income | -366 | -66 | -146 | 1,330 | -55 |
| Pre-tax Income | -3,413 | -15,301 | -13,800 | -12,287 | -11,483 |
| Income Tax | N/A | 97 | N/A | -1,794 | -7,564 |
| Net Income Continuous | -3,413 | -15,398 | -13,800 | -10,493 | -3,919 |
| Net Income Discontinuous | -6,878 | N/A | N/A | N/A | N/A |
| Net Income | $-10,291 | $-35,885 | $-13,800 | $-10,493 | $-3,919 |
| EPS Basic Total Ops | -2.20 | -8.00 | -3.00 | -2.40 | -1.00 |
| EPS Basic Continuous Ops | -0.80 | -3.49 | -3.02 | -2.34 | -0.95 |
| EPS Basic Discontinuous Ops | -1.40 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -2.20 | -8.00 | -3.00 | -2.40 | -1.00 |
| EPS Diluted Continuous Ops | -0.80 | -3.49 | -3.02 | -2.34 | -0.95 |
| EPS Diluted Discontinuous Ops | -1.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,795 | $-13,931 | $-12,346 | $-12,274 | $-10,913 |